Accès ouvert · CC BY

Antimicrobial activity of Zornia apiculata and Ipomoea kituiensis against WHO-priority drug-resistant clinical isolates

Article scientifique 2025 Sciences agricoles, animales et alimentaires › Agronomie (OCDE 4.1) Anglais

Résumé

Background.The rise of antibiotic resistance has become a critical medical concern, prompting the World Health Organization (WHO) to publish a list of priority drug-resistant clinical pathogens. Medicinal plants are considered a potential source for developing novel antimicrobial agents. However, studies on the antimicrobial properties of many such plants remain limited, despite their extensive traditional use. Objective. To evaluate the antimicrobial activity of Zornia apiculata and Ipomoea kituiensis leaf extracts against multidrug-resistant (MDR) bacteria and yeast to support their traditional medicinal use. Methods. An in vitro study assessed the antimicrobial potential of leaf extracts from Z. apiculata and I. kituiensis, sourced from the Omo Valley. Extracts were prepared using selected organic solvents and tested against WHO-prioritized MDR bacterial and fungal isolates. Results. The overall activity indices were 88.3% for Z. apiculata and 83.3% for I. kituiensis. The methanol extract of Z. apiculata showed an activity index of 100%, with inhibition zones of 21.1 ± 1.3–21.8 ± 1.5 mm against Gram-positive and 13.8 ± 1.8–20.8 ± 1.5 mm against Gram-negative bacteria. It also exhibited moderate anti-Candida activity (12.5 ± 0.5 mm). Against MDR isolates, this extract showed inhibition zones of 18.3 ± 1.2–18.5 ± 0.7 mm, with minimum inhibitory concentration (MIC) values of 2.5–10 mg/mL and total antimicrobial activity (TAA) ranging from 9.6–73.8 mL/g. A minimum bactericidal concentration (MBC)/MIC ratio of 0.5 indicated bactericidal action. Both extracts had MIC and MFC values of 5 mg/mL and 10 mg/mL against Candida albicans, respectively (MIC/MFC = 0.5). Conclusion. These findings support the traditional use of Z. apiculata and I. kituiensis for treating infectious diseases in South Omo communities.

Citer ce document

Aklilu, A., Manilal, A., Woldemariam, M., Sahle, S., Seid, M., Salelign, K., Hama, N. H., & John, R. (2025). Antimicrobial activity of Zornia apiculata and Ipomoea kituiensis against WHO-priority drug-resistant clinical isolates. Romanian Journal of Pharmaceutical Practice. https://doi.org/10.37897/rjphp.2025.1-2.2

Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)

Accès au document

Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter

Voir l'article sur le site de la revue

Licence et provenance

Licence : CC BY

Notice moissonnée depuis OpenAlex le 28/09/2026. Le document reste hébergé par sa source.
Voir le document à la source →

Statistiques

Consultations (hors robots) : 17

Téléchargements (hors robots) : 0

Méthode de comptage